BioCentury
ARTICLE | Politics & Policy

Biotech industry urges CFIUS to scale back regulations

October 19, 2019 1:26 AM UTC
Updated on Oct 19, 2019 at 1:33 AM UTC

Biopharma companies and investors are calling on the Treasury Department to scale back plans to restrict foreign investment in U.S. companies that collect genetic information.

About 60 comments to Treasury on the regulations, which implement the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA), were recorded on Regulations.gov as of Oct. 18, a day after the deadline for comments...